Evidence map›Paper›PMID 38675120›Full record

ArticlePharmaceutics2024

Daptomycin Liposomes Exhibit Enhanced Activity against Staphylococci Biofilms Compared to Free Drug.

Foteini Gkartziou, Maria Plota, Charikleia Kypraiou, Iti Gauttam, Fevronia Kolonitsiou, Pavlos Klepetsanis, Iris Spiliopoulou, Sophia G Antimisiaris

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Antibacterial carbon dots.Materials today. Bio · 2025
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Foteini GkartziouDepartment of Pharmacy, School of Health Sciences, University of Patras, 26504 Patras, Greece.
Maria PlotaDepartment of Microbiology, School of Medicine, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-6943-6473
Charikleia KypraiouDepartment of Pharmacy, School of Health Sciences, University of Patras, 26504 Patras, Greece.
Iti GauttamDepartment of Pharmacy, School of Health Sciences, University of Patras, 26504 Patras, Greece.
Fevronia KolonitsiouDepartment of Microbiology, School of Medicine, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-4348-6077
Pavlos KlepetsanisDepartment of Pharmacy, School of Health Sciences, University of Patras, 26504 Patras, Greece.
Iris SpiliopoulouNational Reference Centre for Staphylococci, School of Medicine, University of Patras, 26504 Patras, Greece.
Sophia G AntimisiarisDepartment of Pharmacy, School of Health Sciences, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-2312-5848
University of Patras · GR

Funding

Operational Program "Competitiveness, Entrepreneurship and Innovation" (NSRF 2014-2020), co-financed by Greece and the European Union (European Regional Development Fund) MIS 5031792Operational Program "Human Resources Development, Education and Lifelong Learning 2014-2020", co-financed by Greece and the European Union (European Social Fund-ESF) MIS 5049223
6 · The paper itself

Abstract

The purpose of the present study was to investigate the anti-staphylococcal activity of liposomal daptomycin against four biofilm-producing

Indexed as

bacteriostaticbiofilmdaptomycingrowth inhibitionintegrityliposomesMRSAMRSEzeta-potential

Identifiers

PMID38675120
PMCPMC11054717
OpenAlexW4393201332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.